- Home
- ALEC vs VFL Comparison
ALEC vs VFL Comparison
Compare ALEC & VFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALEC
- VFL
- Stock Information
- Founded
- ALEC 2013
- VFL 1993
- Country
- ALEC United States
- VFL United States
- Employees
- ALEC N/A
- VFL N/A
- Industry
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- VFL Finance/Investors Services
- Sector
- ALEC Health Care
- VFL Finance
- Exchange
- ALEC Nasdaq
- VFL Nasdaq
- Market Cap
- ALEC 101.1M
- VFL 117.3M
- IPO Year
- ALEC 2019
- VFL N/A
- Fundamental
- Price
- ALEC $1.14
- VFL $9.80
- Analyst Decision
- ALEC Buy
- VFL
- Analyst Count
- ALEC 7
- VFL 0
- Target Price
- ALEC $4.10
- VFL N/A
- AVG Volume (30 Days)
- ALEC 809.4K
- VFL 38.0K
- Earning Date
- ALEC 05-07-2025
- VFL 01-01-0001
- Dividend Yield
- ALEC N/A
- VFL 4.16%
- EPS Growth
- ALEC N/A
- VFL N/A
- EPS
- ALEC N/A
- VFL N/A
- Revenue
- ALEC $100,558,000.00
- VFL N/A
- Revenue This Year
- ALEC N/A
- VFL N/A
- Revenue Next Year
- ALEC $376.51
- VFL N/A
- P/E Ratio
- ALEC N/A
- VFL N/A
- Revenue Growth
- ALEC 3.60
- VFL N/A
- 52 Week Low
- ALEC $0.87
- VFL $7.93
- 52 Week High
- ALEC $6.78
- VFL $10.77
- Technical
- Relative Strength Index (RSI)
- ALEC 49.12
- VFL 47.72
- Support Level
- ALEC $0.90
- VFL $9.48
- Resistance Level
- ALEC $1.24
- VFL $9.71
- Average True Range (ATR)
- ALEC 0.11
- VFL 0.17
- MACD
- ALEC 0.04
- VFL 0.03
- Stochastic Oscillator
- ALEC 72.97
- VFL 56.99
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
About VFL abrdn National Municipal Income Fund
Delaware Investments Natl Muni Income is a closed-end investment fund. The Fund seeks to provide current income exempt from regular federal income tax consistent with the preservation of capital. The company's product portfolio includes Mutual funds, Exchange-traded funds, Private markets, Delaware Funds by Macquarie Premier Models, Managed accounts, Closed-end funds, and Variable Insurance Products.